MY ACCOUNT | NEWSLETTER |

Nutritional adequacy and hygiene quality of commercial raw pet-food for dogs, cats


Raw meat-based diets (RMBDs) are widely used as unconventional diets for dogs and cats at different life stages, despite concerns regarding nutritional adequacy and microbial contamination. The aim of this study was to evaluate both the nutritional and hygiene quality profile of RMBDs purchased in Germany. 

For this study, crude nutrients were assessed in 44 RMBDs and compared to declared values. In addition, selected minerals were determined in 31 RMBDs labelled as complete and compared to the minimum requirement for intended species and life stages. 

Aerobic colony count (ACC) and Enterobacteriaceae were used to assess the hygiene quality of 37 commercial RMBDs, while the presence of Salmonella spp. was examined in 10 products. 

Data showed that fat and protein content exceeded tolerated deviation from declared values in 33% and 45% of RMBDs, respectively. Each RMBD showed at least one concern regarding nutrient content. 

The RMBDs had high fat contents (mean 69, range 33-95 g/Mcal) that were negatively correlated with protein (r = -0.74, p < 0.0001). Considerable contaminations by ACC and Enterobacteriaceae were found (2.61 × 108 ± 3.63 × 108 and 3.61 × 106 ± 8.39 x106 CFU/g, respectively). A higher count of Enterobacteriaceae was detected in a frozen RMBDs made of poultry or carcasses from different animals, compared to the thawed counterpart (p = 0.003), as well as compared to other sources, such as beef, horse, and lamb, regardless of the storage condition. Salmonella spp. were found in 2/10 RMBDs. 

In conclusion, this study confirmed that feeding commercial RMBDs might pose a risk to pet health. The authors said the findings indicate a need for strict monitoring of the nutritional and microbiological quality of commercial RMBDs.

Carla Giuditta Vecchiato, et al. “From Nutritional Adequacy to Hygiene Quality: A Detailed Assessment of Commercial Raw Pet-Food for Dogs and Cats." Animals (Basel). 2022 Sep 13;12(18):2395.  doi: 10.3390/ani12182395.

Like1
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top